Generics 13

Originals

Biosimilars

Medical devices

Nutraceuticals

Filters

Montelukast manufacturers

13 products found

Filters

Filters

Filters , active

Country of origin : Argentina

Clear all

13 products found

montelukast

Tablets, chewable 5mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
Argentina
GMP approvals
WHO
Manufacturer #16399
It is a Laboratory of medicinal specialties, founded in the 1950s, with 100% national capital and a 2nd generation family directory. At present, the laboratory has more than 100 permanent collaborators. The company’s vision is to develop pharmaceutical products with excellent quality, strengthen its participation in the domestic market and grow in the external market.

Manufacturer usually replies in 2 days

montelukast

Tablets 10 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
Argentina
GMP approvals
PICS
Manufacturer #17885
The company was established in the initial of 1930s. The company’s mission is to develop and elaborate medicinal specialties of high quality and efficacy to offer trustworthy therapeutic alternatives to health professionals; in short, to offer the national and international medical community, medicines of excellence and quality

Manufacturer usually replies in 10 days

montelukast

Tablets, chewable 4 mg, 5 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
Argentina
GMP approvals
PICS
Manufacturer #17885
The company was established in the initial of 1930s. The company’s mission is to develop and elaborate medicinal specialties of high quality and efficacy to offer trustworthy therapeutic alternatives to health professionals; in short, to offer the national and international medical community, medicines of excellence and quality

Manufacturer usually replies in 10 days

Want to see all 13 products?

Subscribe today to benefit from:

  • Streamlined product sourcing - the leading CTD dossiers database focused on finished dosage formulations

  • Direct negotiations - connect and negotiate directly with manufacturers without any brokerage fee

  • Increased profitability - secure the best commercial terms for your business by comparing offers from several manufacturers

Request Subscription

Montelukast Manufacturers

Montelukast is a medication used to treat asthma symptoms such as wheezing, trouble breathing, tightness of the chest, and coughing in adults and children aged 12 months and up. Montelukast is also used to avoid bronchoconstriction in children and adults aged 6 and up during exercise. Montelukast is also used to treat symptoms of allergic rhinitis, which occurs only at particular periods of the year and is characterised by sneezing and a stuffy, runny, or itchy nose in adults and children aged 2 and up. Only children and adults who could be cured with other drugs should take montelukast to treat seasonal or perpetual allergic rhinitis. Montelukast belongs to the class of drugs known as leukotriene antagonists.

How Does Montelukast Work?

It works by preventing the body from producing chemicals that trigger asthma and allergic rhinitis symptoms. Eicosanoids such as LTC4, LTD4, and LTE4 are produced by a number of cells, including mast cells and eosinophils. When CysLT binds to corresponding CysLT receptor sites, such as CysLT type-1 receptors found on breathing airway smooth muscle, airway monocytes, and main products cells like basophils and some specific myeloid stem cells, activities that aid asthma and rhinitis disease pathogenesis are stimulated.

Wholesale Price of Montelukast

Based on the drugstore you visit, montelukast oral tablet 10 mg costs roughly $11 for a pack of 30 tablets. Montelukast is available for sale from a variety of Montelukast vendors at a range of costs. Prices are applicable just for cash consumers and do not apply to insurance policies. Montelukast suppliers, on the whole, are in favor of patient aid initiatives. This cost may differ among dealers. Its price may vary depending on the country of origin, wholesale costs incurred by manufacturing companies, supplier pricing, and similar factors. Pharmaceutical corporations generally support patient support programs.

Navigating our pharmaceutical marketplace

Being a global B2B pharmaceutical online marketplace, Pipelinepharma is structured to simplify pharmaceutical deals by providing you with an intuitive interface that is easy to engage with. The selection of Montelukast offerings can be narrowed down with the use of filters and easily weighed against one another according to medication prices and commercial terms. The advanced filters help you filter out the countries for this substance manufacturer and Montelukast suppliers that you are looking for. These also enable you to check the dossier status of this medicine and the GMP approvals of the different variants of Montelukast. Also, each manufacturer or supplier product description contains essential information about this substance including clinical data, stability zones, countries where Montelukast is already registered in. Manufacturers also have special, and delivery terms.

Establishing commercial ties

If you are a pharmaceutical licensing company or a distributor you can enter into deals or negotiations over these medicine offers with manufacturing companies after completing the free registration process and joining our online marketplace. This helps to ensure that you conclude the pharmaceutical deal at a reasonable cost and achieve the best cost/benefit ratio for your company while bypassing lengthy sourcing, negotiation, and order process. Once you have finalized a deal, you can look forward to a long-lasting business relationship with the Montelukast suppliers. This way, the marketplace allows you as a distributor to skip the process of making a list of product manufacturers every time you are looking for in-licensing or distribution deals.

Quality Assurance

To keep up to the quality standards other than Good Manufacturing Practice approvals that this medicine manufacturers list has, we qualify their companies before they are boarded on the platform. This allows us to screen Montelukast manufacturers for the quality of the pharmaceutical products’ dossiers and protect against the risk of possible malpractices.

Interested in becoming a subscriber?

Please provide the following information to receive an offer tailored to your business needs

  1. Number of company users for the subscription
  2. The rough number of products you would like to source in the 12 months
  3. Target market(s) for commercialisation